FARMAKOTERAPIYa BEREMENNYKh: PROSTYE PRAVILA SOVREMENNOSTI
- Authors: Radzinskiy V.E1, Totchiev G.F1, Panov A.E1
-
Affiliations:
- Issue: No 3 (2013)
- Pages: 77-79
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/280297
- ID: 280297
Cite item
Open Access
Access granted
Abstract
The aggressive expansion in the market of medicine preparations has contributed to the rise of the number of registered drug’s side effects, especially during pregnancy. The influence of drugs during pregnancy is still poorly understood area, and opinions on the safety of their use are very controversial. Potentials for prevention of the negative effects of pharmacotherapy or their significant reduction consist of understanding of principles of pharmacotherapy, strict conformity of drugs used with modern knowledge level, as well as a competent interpretation of data of the clinical monitoring of pregnant women. All this allows to avoid both diagnostic and therapeutic polypragmasy.
Keywords
Full Text
References
- Айламазян Э.К., Кулаков В.И., Радзинский В.Е., Савельева Г.М. Акушерство. Национальное руководство. 2007. 1197 c.
- Бабанов С.А., Агаркова И.А. Особенности применения лекарственных средств в период беременности и лактации // Гинекология 2010. № 2. Т. 12.
- Сидельникова В.М. Эндокринология беременности в норме и патологии. М., 2007.
- Стриженок Е.А, Гудков И.В., Страчунский Л.С. Применение лекарственных средств при беременности: результаты многоцентрового фармакоэпидемиологического исследования // Клин. микробиология антимикр. химиотер. 2007. Т. 9. № 2. С. 162-75.
- Ушкалова Е.А., Ткачева О.Н., Чухарева Н.А. Проблемы безопасности применения лекарственных средств во время беременности и кормления грудью // Акушерство и гинекология 2011. № 2. С. 4-7.
- Шешукова Н.А., Боровкова Е.И. Фармакотерапия при невынашивании беременности // Вопросы гинекологии, акушерства и перинатологии 2009. Т. 8. № 6. С. 79-82.
- Brucker MC. Top ten pharmacologic considerations in pregnancy. Program and abstracts of the 5th Annual Conference of the National Association of Nurse Practitioners in Women's Health; September 27-29, 2002; Scottsdale, Arizona.
- Kalinka J, Szekers-Bartho J. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion Am J Reprod Immunol 2005;53:1-6.
- Mengue SS, Schenkel EP, Duncan BB, Schmidt MI. Drug use by pregnant women in six Brazilian cities. Rev Saude Publica 2001;35:415-20.
- Weiss SR. Prescription Medication Use in Pregnancy. Medscape Pharmacotherapy 2000;2(2).
Supplementary files
